Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Biol Sex Differ. 2011 Dec 12;2:14. doi: 10.1186/2042-6410-2-14.
Cardiovascular disease remains the primary cause of death worldwide. In the US, deaths due to cardiovascular disease for women exceed those of men. While cultural and psychosocial factors such as education, economic status, marital status and access to healthcare contribute to sex differences in adverse outcomes, physiological and molecular bases of differences between women and men that contribute to development of cardiovascular disease and response to therapy remain underexplored.
This article describes concepts, methods and procedures to assist in the design of animal and tissue/cell based studies of sex differences in cardiovascular structure, function and models of disease.
To address knowledge gaps, study designs must incorporate appropriate experimental material including species/strain characteristics, sex and hormonal status. Determining whether a sex difference exists in a trait must take into account the reproductive status and history of the animal including those used for tissue (cell) harvest, such as the presence of gonadal steroids at the time of testing, during development or number of pregnancies. When selecting the type of experimental animal, additional consideration should be given to diet requirements (soy or plant based influencing consumption of phytoestrogen), lifespan, frequency of estrous cycle in females, and ability to investigate developmental or environmental components of disease modulation. Stress imposed by disruption of sleep/wake cycles, patterns of social interaction (or degree of social isolation), or handling may influence adrenal hormones that interact with pathways activated by the sex steroid hormones. Care must be given to selection of hormonal treatment and route of administration.
Accounting for sex in the design and interpretation of studies including pharmacological effects of drugs is essential to increase the foundation of basic knowledge upon which to build translational approaches to prevent, diagnose and treat cardiovascular diseases in humans.
心血管疾病仍然是全球范围内的主要死亡原因。在美国,女性因心血管疾病导致的死亡人数超过男性。尽管文化和社会心理因素(如教育、经济地位、婚姻状况和获得医疗保健的机会)导致了不良结局的性别差异,但导致心血管疾病发展和治疗反应差异的女性和男性之间的生理和分子基础仍未得到充分探索。
本文描述了协助设计心血管结构、功能和疾病模型的动物和组织/细胞基础研究中性别差异的概念、方法和程序。
为了解决知识空白,研究设计必须纳入适当的实验材料,包括物种/品系特征、性别和激素状态。确定一个特征是否存在性别差异,必须考虑动物的生殖状态和历史,包括那些用于组织(细胞)收获的动物,例如在测试时、发育过程中或妊娠次数中是否存在性腺类固醇。在选择实验动物类型时,还应考虑饮食要求(影响植物雌激素摄入的大豆或植物性饮食)、寿命、雌性发情周期的频率以及研究疾病调节的发育或环境因素的能力。破坏睡眠/觉醒周期、社交互动模式(或社交隔离程度)或处理方式引起的压力会影响与性甾体激素激活的途径相互作用的肾上腺激素。必须注意选择激素治疗和给药途径。
在设计和解释研究时考虑性别,包括药物的药理作用,对于增加预防、诊断和治疗人类心血管疾病的基础知识基础至关重要。